EVMN
Evommune
EVMN • NYSE
Evommune is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Luis C. Pena, with a market cap of $525.2M.
CEOLuis C. Pena
Next Earnings
Upcoming earnings announcement for Evommune
Date
Thursday, May 7, 2026 (in 3 months)
Timing
After Market Close (5:46 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.62
Earnings History
Past 1 earnings report for Evommune
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | Q3 2025 | -$8.07 | — | $10.0K | — |  10-Q |